So I decided to crunch some numbers. 5 patients did the full trial with 100% success rate. The normal drugs for treating Hep C that were part of the trial (IFN/RBV) were mentioned to have a 68.8% success rate on their own in Thailand (it's more like 75% - 80% success rate elsewhere). The chance of 5 patients all having success at 68.8% is a 15.4% chance (if the trial was done elsewhere it would be more like 32% chance). So in other words, there's a 15.4% chance the BIT225 did nothing and it was just the standard drugs doing all the work.
So yeah, I dunno. Certainly needs further study, this study alone just isn't enough to conclusively say this drug works or not. Not trying to downramp or anything, just doing the numbers since I don't see any posts doing that.
- Forums
- ASX - By Stock
- BIT
- Ann: BIT225 TRIAL RESULTS SHOW EFFECTIVE CURE OF HEPATITIS C
Ann: BIT225 TRIAL RESULTS SHOW EFFECTIVE CURE OF HEPATITIS C, page-9
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $23.46M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $8.415K | 322.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 37530 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.026 |
7 | 804946 | 0.025 |
2 | 3453333 | 0.024 |
1 | 130000 | 0.023 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 37530 | 1 |
0.028 | 145600 | 2 |
0.029 | 260000 | 2 |
0.030 | 49844 | 3 |
0.031 | 280868 | 5 |
Last trade - 15.23pm 16/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |